ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 36 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $2,000 | 0.0% | 4,650 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | +100.0% | 4,650 | -26.4% | 0.00% | – |
Q2 2019 | $1,000 | -75.0% | 6,320 | -48.1% | 0.00% | – |
Q1 2019 | $4,000 | -20.0% | 12,180 | +401.0% | 0.00% | – |
Q4 2018 | $5,000 | -77.3% | 2,431 | -78.5% | 0.00% | – |
Q3 2018 | $22,000 | +100.0% | 11,328 | +99.9% | 0.00% | – |
Q2 2018 | $11,000 | – | 5,668 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cambridge Investment Research Advisors, Inc. | 12,254,080 | $1,349,000 | 0.01% |
SABBY MANAGEMENT, LLC | 470,548 | $52,000 | 0.01% |
jvl associates llc | 58,500 | $6,000 | 0.01% |
WINTON GROUP Ltd | 717,882 | $79,000 | 0.00% |
REILLY FINANCIAL ADVISORS, LLC | 172,031 | $19,000 | 0.00% |
THOROUGHBRED FINANCIAL SERVICES, LLC | 21,000 | $2,000 | 0.00% |
RETIREMENT INCOME SOLUTIONS, INC | 32,060 | $3,000,000 | 0.00% |
JANE STREET GROUP, LLC | 223,538 | $25,000 | 0.00% |
Sequoia Financial Advisors, LLC | 15,000 | $2,000 | 0.00% |
UBS Group AG | 105,639 | $12,000 | 0.00% |